Download FREE Report Sample
Download Free sampleDocetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Docetaxel Market contains market size and forecasts of Docetaxel in global, including the following market information:
Global Docetaxel Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Docetaxel Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Docetaxel companies in 2021 (%)
The global Docetaxel market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
20 mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Docetaxel include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma and Jiangsu Aosaikang Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Docetaxel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Docetaxel Market Segment Percentages, by Type, 2021 (%)
20 mg/ml
40 mg/ml
60 mg/ml
Global Docetaxel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Docetaxel Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Global Docetaxel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Docetaxel Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Docetaxel revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Docetaxel revenues share in global market, 2021 (%)
Key companies Docetaxel sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Docetaxel sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
